Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience from 2 Tertiary Referral Centers
- Morellá Fernández, M.
- Balsalobre Yago, J.
- Martínez García, J.
- Peláez Gutiérrez, M.
- López Muñoz, A.
- Silvestre Ballesta, A.I.
- Sánchez Lafuente, B.
- Martínez Martín, I.
- Cerezuela Fuentes, P.
Journal:
Actas Dermo-Sifiliograficas
ISSN: 1578-2190, 0001-7310
Year of publication: 2024
Type: Article